Preventing unsafe abortions for enhanced sexual and reproductive health rights
Ensuring sustained and strengthened injectables access for women and girls.
Expanding access to Hormonal Intrauterine Device in support of sexual and reproductive heath and rights (SRHR).
SEMA Reproductive Health’s first Annual Report.
Shaping Equitable Market Access for Reproductive Health.
SEMA unpacks this space into three distinct, yet interconnected, market levels in order to promote dialogue around solutions and build support for specific interventions that can improve access to SRH products.
This strategy represents a culmination of that work – learning from the past, outlining the present and building toward a new era for sexual and reproductive health markets.